Literature DB >> 25467159

Chemical constituents isolated from Disporum viridescens leaves and their inhibitory effect on nitric oxide production in BV2 microglial cells.

Namki Cho1, Heejung Yang2, Jung Wha Kim1, Young Choong Kim1, Sang Hyun Sung3.   

Abstract

Excessive NO (nitric oxide) has been associated with the pathogenesis of various neurodegenerative diseases including Alzheimer's disease (AD). In our screening system using LPS-activated BV2 microglial cells, the methanolic extract of Disporum viridescens leaves was found to have significant NO inhibitory activity. Bioactivity-guided isolation yielded a new phenylpropanoid characterized as 4-ally-2,6-dimethoxyphenyl 1-O-β-D-apiofuranosyl (1→6)-β-D-glucopyranoside (12) with 21 known compounds from the leaves of D. viridescens. Among them, compounds 2 and 4 significantly inhibited NO production. Thus, we further elucidated the anti-inflammatory mechanism of these lignans. Especially, compound 4 inhibited the expression of both inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) through the suppression of the MAPK signaling pathway. Taken together, the anti-inflammatory activities of the active constituents isolated from D. viridescens leaves could have therapeutic potential against neurodegenerative diseases.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  BV2 microglial cells; Disporum viridescens leaves; Lignan; NO; Phenylpropanoid

Mesh:

Substances:

Year:  2014        PMID: 25467159     DOI: 10.1016/j.bmcl.2014.10.068

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  Illiciumlignans G-O from the leaves of Illicium dunnianum and their anti-inflammatory activities.

Authors:  Sen-Ju Ma; Hai-Bo Li; Ting Li; Zhen-Zhen Su; Zhen-Zhong Wang; Xin-Sheng Yao; Wei Xiao; Yang Yu
Journal:  RSC Adv       Date:  2021-09-15       Impact factor: 4.036

2.  Bupleurum marginatum Wall.ex DC in Liver Fibrosis: Pharmacological Evaluation, Differential Proteomics, and Network Pharmacology.

Authors:  Xiujie Liu; Yu Shi; Yinghui Hu; Ke Luo; Ying Guo; Weiwei Meng; Yulin Deng; Rongji Dai
Journal:  Front Pharmacol       Date:  2018-05-17       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.